Svasti Haricharan

This study identifies molecular differences in HR+ breast cancer between Black and White women, linking structural factors like poverty to tumor biology and immune signatures.

This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.

This study identifies how specific cell cycle checkpoint kinase dysregulations influence cancer subtype, metastasis, and treatment response in breast cancer.